Therapure Biomanufacturing Receives Four CMO Leadership Awards in Quality, Reliability, Productivity and Regulatory Categories
Mississauga, Ontario, Canada (March 19, 2015) – Therapure Biomanufacturing, the contract development and manufacturing division of Therapure Biopharma Inc., announces that it has received 2015 CMO Leadership Awards for its exemplary efforts in the areas of quality, reliability, productivity and regulatory.
“For the fourth consecutive year, we are honored to receive CMO Leadership Awards. This year we were recognized in the categories of quality, reliability, productivity, and regulatory. I am particularly proud to receive the quality award, which is defined as treating a project as if it were our own,” says Therapure’s President and CEO, Nick Green. “This achievement is only possible through the continued diligence of our employees, who are passionate about developing and manufacturing the highest quality biotherapeutics for our clients and their patients.”
The Life Science Leader’s annual CMO Leadership Awards Ceremony was held March 18, 2015, in New York, New York. The awards are based on industry research conducted by Nice Insight, which incorporates the common filters used by pharmaceutical executives when selecting CMOs and has the added filter of peer feedback. Unlike other industry awards, the only recommendations that count towards the CMO Leadership Awards are those from the pharmaceutical and biopharmaceutical companies that are using contract manufacturing services.
About Therapure Biomanufacturing
Therapure Biomanufacturing is a global contract development and manufacturing organization (CDMO) offering integrated services for developing, manufacturing, purifying and packaging complex biological therapeutics. Its scientific and manufacturing expertise, as well as its flexible, state-of-the-art cGMP facility, provides clients with optimal biomanufacturing solutions to advance their biotherapeutics from discovery to market.
For more information, please visit www.therapurebio.com/CDMO/. Meet the Therapure CDMO team at the Interphex show in New York, April 21 to 23, 2015, at Booth #1353.
About Therapure Biopharma Inc.
Therapure Biopharma Inc. is an integrated biopharmaceutical company focused on complex biological therapeutics and technologies that can provide new options for patient care. Therapure Biopharma Inc. has two divisions: Therapure Biomanufacturing and Therapure Innovations, its drug discovery and development division. Therapure Biopharma Inc. operates out of two facilities located in Mississauga: a 130,000 sq. ft. cGMP facility that includes biomanufacturing, research and quality control laboratories and is built to meet FDA (US), HPFB (Canada), EMA (Europe) and MHRA (UK) standards, and a new 43,000 sq. ft. facility housing 30,000 sq. ft. of cGMP warehouse.
For more information, please visit www.therapurebio.com
Director, Marketing and Special Projects